Literature DB >> 25154761

MicroRNA-146a rs2910164 polymorphism is associated with susceptibility to non-small cell lung cancer in the Chinese population.

Youchao Jia1, Aimin Zang, Yanhong Shang, Hua Yang, Zizheng Song, Zhiyu Wang, Lili Ren, Yaning Wei, Ling Hu, Hongyun Shi, Hefei Li.   

Abstract

The aim of the present study was to investigate the association of single nucleotide polymorphisms (SNP) of the microRNA-146a (miR-146a) genes with the risk of nonsmall cell lung cancer (NSCLC). The genotyping of miR-146a rs2910164 polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The results showed that CC genotype and C allele distribution in the NSCLC patient were significantly higher than that of the controls (P=0.03 and 0.03, respectively). No significant differences were found between the two subgroups when stratified by clinical characteristics including age, sexual, smoke status, histological type, lymph node metastasis and clinical stage. In addition, the expression of miR-146a was detected by the Taqman real-time PCR. It demonstrated that the miR-146a expression was significantly decreased in NSCLC patients compared with that of nonmalignant lung tissues (P=0.01). In addition, the miR-146a expression of CC genotypes subgroup was significantly decreased than of GC/GG genotype subgroup in tumor tissues (P=0.0022). It confirmed that the SNP rs2910164 could functionally affect the miR-146a expression levels. In conclusion, it showed that the rs2910164 polymorphism of miR-146a is associated with the risk of NSCLC in the Chinese population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25154761     DOI: 10.1007/s12032-014-0194-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.

Authors:  Kyong-Ah Yoon; Hyekyoung Yoon; Sohee Park; Hee-Jin Jang; Jae Ill Zo; Hyun-Sung Lee; Jin Soo Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2012-07-18       Impact factor: 5.209

2.  Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers.

Authors:  Serena Vinci; Stefania Gelmini; Nicola Pratesi; Simona Conti; Francesca Malentacchi; Lisa Simi; Mario Pazzagli; Claudio Orlando
Journal:  Clin Chem Lab Med       Date:  2011-09-09       Impact factor: 3.694

Review 3.  Genetic variation in microRNA networks: the implications for cancer research.

Authors:  Bríd M Ryan; Ana I Robles; Curtis C Harris
Journal:  Nat Rev Cancer       Date:  2010-06       Impact factor: 60.716

Review 4.  Genetics of preneoplasia: lessons from lung cancer.

Authors:  Ignacio I Wistuba
Journal:  Curr Mol Med       Date:  2007-02       Impact factor: 2.222

5.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 6.  Common gene polymorphisms, cancer progression and prognosis.

Authors:  Alexandre Loktionov
Journal:  Cancer Lett       Date:  2004-05-10       Impact factor: 8.679

Review 7.  MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises.

Authors:  D Cortinovis; V Monica; F Pietrantonio; G L Ceresoli; C M La Spina; L Wannesson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer.

Authors:  Krystian Jazdzewski; Sandya Liyanarachchi; Michal Swierniak; Janusz Pachucki; Matthew D Ringel; Barbara Jarzab; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

9.  Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Authors:  Amit Dutt; Alex H Ramos; Peter S Hammerman; Craig Mermel; Jeonghee Cho; Tanaz Sharifnia; Ajit Chande; Kumiko Elisa Tanaka; Nicolas Stransky; Heidi Greulich; Nathanael S Gray; Matthew Meyerson
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

Review 10.  Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.

Authors:  Marko Jakopovic; Anish Thomas; Sanjeeve Balasubramaniam; David Schrump; Giuseppe Giaccone; Susan E Bates
Journal:  Front Oncol       Date:  2013-10-09       Impact factor: 6.244

View more
  19 in total

1.  Platelet VEGF and serum TGF-β1 levels predict chemotherapy response in non-small cell lung cancer patients.

Authors:  Bao-Hong Fu; Zhan-Zhao Fu; Wei Meng; Tao Gu; Xiao-Dong Sun; Zhi Zhang
Journal:  Tumour Biol       Date:  2015-03-29

2.  Effects of common polymorphisms in miR-146a and miR-196a2 on lung cancer susceptibility: a meta-analysis.

Authors:  Yan-Gang Ren; Xiao-Ming Zhou; Zhi-Gang Cui; Gang Hou
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 3.  Association between miR-146a rs2910164 polymorphism and specific cancer susceptibility: an updated meta-analysis.

Authors:  Xia Hao; Lingzi Xia; Ruoyi Qu; Xianglin Yang; Min Jiang; Baosen Zhou
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

4.  miR-1290 is a potential prognostic biomarker in non-small cell lung cancer.

Authors:  Dongping Mo; Bing Gu; Xue Gong; Lei Wu; Hong Wang; Ye Jiang; Bingfeng Zhang; Meijuan Zhang; Yan Zhang; Jian Xu; Shiyang Pan
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

5.  Functional miRNA variants affect lung cancer susceptibility and platinum-based chemotherapy response.

Authors:  Chao Fang; Xiang-Ping Li; Yi-Xin Chen; Na-Yiyuan Wu; Ji-Ye Yin; Wei Zhang; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

6.  Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.

Authors:  Ji-Chang Han; Xian-Dong Li; Jin Du; Feng Xu; Yu-Ju Wei; Hong-Bing Li; Yi-Jie Zhang
Journal:  World J Surg Oncol       Date:  2015-01-14       Impact factor: 2.754

7.  Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer.

Authors:  Bing Zhou; Heyun Xu; Kewei Ni; Xuming Ni; Jian Shen
Journal:  Med Sci Monit       Date:  2016-05-09

8.  Characteristics of miRNA-SNPs in healthy Japanese subjects and non-small cell lung cancer, colorectal cancer, and soft tissue sarcoma patients.

Authors:  Koki Katayama; Shimon Nakashima; Hiroo Ishida; Yutaro Kubota; Masataka Nakano; Tatsuki Fukami; Yasutsuna Sasaki; Ken-Ichi Fujita; Miki Nakajima
Journal:  Noncoding RNA Res       Date:  2021-06-27

9.  Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas.

Authors:  Michael A Winkler; Christian Dib; Alexander V Ljubimov; Mehrnoosh Saghizadeh
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

10.  Effects of CYP3A5 genetic polymorphism and smoking on the prognosis of non-small-cell lung cancer.

Authors:  Li-Peng Jiang; Zhi-Tu Zhu; Chun-Yan He
Journal:  Onco Targets Ther       Date:  2016-03-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.